GlassScriptPhysician profile
Everold Haffizulla
NPI 1215009386
$17,046.62
in general payments reported to CMS, 2019-2025
73 companies · $2,110 in 2025
The $2,110 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,933 · 2020: $2,415 · 2021: $2,847 · 2022: $2,797 · 2023: $2,476 · 2024: $2,470 · 2025: $2,110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,055.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,123.63 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Amgen INC. | $1,614.43 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,477.86 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $965.77 | 2019-2025 | Jardiance, Synjardy |
| Glaxosmithkline, LLC. | $863.68 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $860.05 | 2019-2025 | |
| Lilly USA, LLC | $810.91 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $730.25 | 2019-2024 | Xarelto, Spravato |
| Mallinckrodt Hospital Products INC. | $725.04 | 2020-2025 | Acthar |
| Cumberland Pharmaceuticals, INC. | $553.17 | 2019-2023 | Kristalose, Reditrex, Sancuso |
| Bayer Healthcare Pharmaceuticals INC. | $455.76 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $360.23 | 2019-2025 | |
| Horizon Therapeutics Plc | $347.66 | 2019-2022 | |
| Exact Sciences Corporation | $301.72 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $280.46 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $279.96 | 2019-2025 | Veozah |
| Esperion Therapeutics, INC. | $229.16 | 2020-2025 | Nexletol |
| Ibsa Pharma INC. | $220.55 | 2020-2025 | Tirosint, Tirosint, Licart |
| Janssen Biotech, INC. | $219.58 | 2021-2025 | Tremfya, Simponi Aria, Remicade |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $213.09 | 2019-2025 | Xifaxan |
| Abbvie INC. | $202.60 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $190.82 | 2019-2022 | |
| Amarin Pharma, INC. | $177.06 | 2019-2021 | |
| Ucb, INC. | $154.05 | 2023-2025 | Cimzia, Bimzelx |
| Dexcom, INC. | $147.98 | 2021-2025 | Dexcom G6 Transmitter |
| Paratek Pharmaceuticals, INC. | $147.05 | 2023-2025 | Nuzyra, Xhance |
| Sanofi-Aventis U.S. LLC | $138.69 | 2019-2023 | |
| Radius Health, INC. | $133.80 | 2019-2025 | |
| Mylan Specialty L.P. | $133.62 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $131.47 | 2020-2021 | |
| E.R. Squibb & Sons, L.L.C. | $127.68 | 2021-2024 | Eliquis, Camzyos |
| Medtronic, INC. | $111.60 | 2024-2025 | Intellis Adaptivestim, Minimed 780g |
| Almatica Pharma LLC | $103.44 | 2023 | Loreev Xr, Sertraline Hcl |
| Eisai INC. | $101.70 | 2020-2021 | |
| Ani Pharmaceuticals, INC. | $91.55 | 2023-2025 | Purified Cortrophin Gel |
| Heartflow, INC. | $90.15 | 2023 | Ffrct |
| Abbott Laboratories | $85.15 | 2019-2020 | |
| Corcept Therapeutics | $84.80 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $76.93 | 2024 | Voquezna |
| Regeneron Healthcare Solutions, INC. | $60.88 | 2019 | |
| Si-Bone, INC. | $59.44 | 2019 | |
| Biogen, INC. | $54.09 | 2021-2022 | |
| Redhill Biopharma INC. | $52.31 | 2020-2021 | |
| Altathera Pharmaceuticals LLC | $46.37 | 2023-2024 | Sotalol Hydrochloride |
| Arbor Pharmaceuticals, INC. | $44.62 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $42.52 | 2020-2021 | |
| Intuitive Surgical, INC. | $40.67 | 2022 | |
| Idorsia Pharmaceuticals US INC | $38.93 | 2023 | Quviviq |
| Insmed, INC. | $35.45 | 2025 | Brinsupri, Arikayce |
| Eyevance Pharmaceuticals LLC | $34.78 | 2021 | |
| Vanda Pharmaceuticals INC. | $29.88 | 2021 | |
| Currax Pharmaceuticals LLC | $28.82 | 2022 | |
| Zyla Life Sciences, INC. | $27.94 | 2019 | |
| Vivus LLC | $24.43 | 2020-2021 | |
| Medicure Pharma INC. | $24.42 | 2025 | Zypitamag |
| Lundbeck LLC | $24.34 | 2024 | Rexulti |
| Kowa Pharmaceuticals America, INC. | $24.27 | 2020 | |
| Kvk-Tech, INC. | $23.80 | 2019 | |
| Evoke Pharma, INC. | $22.65 | 2021 | |
| Tonix Medicines, INC. | $22.54 | 2025 | Tonmya |
| Azurity Pharmaceuticals, INC. | $22.16 | 2025 | Alvesco |
| Relievant Medsystems, INC. | $22.07 | 2023 | Intracept |
| Insulet Corporation | $20.41 | 2023 | Omnipod |
| Ethicon US, LLC | $19.90 | 2022 | |
| Optinose US, INC. | $18.68 | 2025 | |
| Phadia US INC. | $17.75 | 2019 | |
| Allergan, INC. | $17.08 | 2020 | |
| Mallinckrodt Enterprises LLC | $16.74 | 2019 | |
| Depuy Synthes Sales INC. | $14.79 | 2025 | Orthovisc, Monovisc |
| Pharming Healthcare, INC. | $13.46 | 2023 | Ruconest |
| Xeris Pharmaceuticals, INC. | $13.25 | 2024 | Gvoke Hypopen |
| Vistapharm, INC. | $12.83 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.25 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Everold Haffizulla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.